T1D Exchange, a Boston-based nonprofit organization dedicated to accelerating therapies and improving care in type 1 diabetes, opened the call for applications for the 2018 Diabetes Innovation Challenge, a global competition to identify, nurture and fast-track innovative scientific and clinical solutions for diabetes. Launched earlier this year, we received submissions from a highly-qualified field of 60 applicants.

You are invited to attend this year’s live pitch-off event to identify and accelerate transformational advancements in diabetes research and care. As an attendee you will have the opportunity to preview poster presentations from the selected pool of 30 semifinalists, followed by a pitch-off event showcasing the ten finalists. A People’s Choice award will also be given to the recipient of the most votes during the public voting period.

The 2018 Diabetes Innovation Challenge is supported by a number of sponsors, including lead sponsors JDRF and The Leona M. and Harry B. Helmsley Charitable Trust.

T1D Exchange knows that breakthroughs in diabetes cannot and will not happen without inspired innovation. Please join us this May as we award up to $250,000 in cash and in-kind services to the top three innovative ideas and solutions that could change the quality of life for millions of people who are living with diabetes.